Browsing Tag
biopharma innovation
2 posts
How oral obesity drugs are changing treatment access: A look at semaglutide, amycretin, and orforglipron
Oral GLP-1 drugs like semaglutide, amycretin, and orforglipron are redefining obesity care. Explore trial data, payer impact, and what’s ahead for access and scale.
Accenture invests in Turbine to advance AI-powered drug discovery
Accenture (NYSE: ACN) has announced a strategic investment through Accenture Ventures into Turbine, a pioneering predictive simulation company.…